Prelude Capital Management’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,466	Closed	-$538K	–	1275
2025 Q4	$538K	Buy	+15,466	New	+$1.21M	0.04%	502
2025 Q2	–	Sell	-14,744	Closed	-$1.68M	–	1054
2025 Q1	$1.68M	Buy	+14,744	New	+$897K	0.17%	181
2020 Q3	–	Sell	-5,978	Closed	-$101K	–	1947
2020 Q2	$101K	Buy	5,978 +2,059	+53%	+$28.9K	0.02%	955
2020 Q1	$47K	Sell	3,919 -5,964	-60%	-$73.8K	0.01%	774
2019 Q4	$120K	Buy	+9,883	New	+$138K	0.02%	1031
2019 Q3	–	Sell	-4,100	Closed	-$46K	–	1793
2019 Q2	$46K	Buy	4,100 +2,500	+156%	+$27.9K	﹤0.01%	1131
2019 Q1	$19K	Sell	1,600 -75,906	-98%	-$943K	﹤0.01%	1320
2018 Q4	$1.03M	Buy	77,506 +20,737	+37%	+$274K	0.11%	311
2018 Q3	$796K	Sell	56,769 -1,000	-2%	-$14K	0.06%	415
2018 Q2	$908K	Buy	57,769 +1,000	+2%	+$17.4K	0.07%	355
2018 Q1	$934K	Buy	56,769 +4,968	+10%	+$92.1K	0.08%	296
2017 Q4	$936K	Buy	51,801 +19,452	+60%	+$352K	0.09%	267
2017 Q3	$624K	Buy	32,349 +19,020	+143%	+$284K	0.06%	325
2017 Q2	$157K	Sell	13,329 -4,200	-24%	-$45.7K	0.02%	650
2017 Q1	$192K	Sell	17,529 -19,900	-53%	-$175K	0.02%	576
2016 Q4	$272K	Buy	+37,429	New	+$293K	0.04%	469
2016 Q1	–	Sell	-11,900	Closed	-$59K	–	1308
2015 Q4	$59K	Hold	11,900	–	–	0.01%	1008
2015 Q3	$45K	Buy	+11,900	New	+$60.4K	0.01%	1090